Thomson, D. J. (2015) “Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma”, Acta Oncologica, 54(1), pp. 88–98. doi: 10.3109/0284186X.2014.958528.